companydata.dkNOVARTIS HEALTHCARE A/S: Financial statements 2024
CVR: 20575786
NOVARTIS HEALTHCARE A/S (CVR 20575786) has filed annual accounts for 2024. In 2024, the company reported revenue of DKK 937,871,000 and a net result of DKK 13,166,000 compared with DKK 251,036,000 the year before. That is an increase of 2.5% compared with the year before. The profit margin was 1.4%. Equity amounted to DKK 254,123,000. The solvency ratio was 57.5%. The company had 128 employees in the financial year.
- Revenue
- 937,871,000 kr.
- Gross Profit
- 134,021,000 kr.
- Profit/Loss
- 13,166,000 kr.
- Equity
- 254,123,000 kr.
- Total Assets
- 442,225,000 kr.
- Employees
- 128
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 937.9 mio. | 134 mio. | 13.2 mio. | 254.1 mio. | 128 |
| 2023 | 914.8 mio. | 160.2 mio. | 251 mio. | 541 mio. | 121 |
| 2022 | 592.7 mio. | 193.4 mio. | 56.2 mio. | 289.9 mio. | 126 |
| 2021 | 701.9 mio. | 170.5 mio. | 84.9 mio. | 233.8 mio. | 125 |
| 2020 | 1 mia. | 196.8 mio. | 127.7 mio. | 148.9 mio. | 131 |
How creditworthy is NOVARTIS HEALTHCARE A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
As of December 19, 2024, Frances Clare Milnes has joined the board of directors of NOVARTIS HEALTHCARE A/S.
As of December 19, 2024, Johan Mikael Olof Kahlström has left the board of directors of NOVARTIS HEALTHCARE A/S.
NOVARTIS HEALTHCARE A/S has won the tender "Rammeaftale om køb af Luxturna (voretigen neparvovec)" issued by Amgros I/S worth 20,000,000 DKK.
NOVARTIS HEALTHCARE A/S has published its annual report for 2023. Revenue came to DKK 914,827,000, and the net result was DKK 251,036,000.
About NOVARTIS HEALTHCARE A/S
NOVARTIS HEALTHCARE A/S is a Danish company of the type Aktieselskab based in København S, founded in 1997. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Peter Drøidal. The company is owned by Novartis Pharma AG. The company has 125 employees.